Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity
Marco Capezzone(University of Siena), Furio Pacini, Silvano Capitani(University of Ferrara), Kalliopi Pazaitou‐Panayiotou(Theageneio General Hospital), Paolo Toti(University of Siena), Lucia Brilli(University of Siena), Andrea Pammolli(University of Siena), Silvia Cantara(University of Siena), Giuseppe Caruso(University of Siena), Giulia Busonero(University of Siena), Anton Ferdinando Carli(University of Siena), Stefania Marchisotta(University of Siena)
Cited by 144
Related Papers
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
|The Lancet|2017|843
A Comparison of Recombinant Human Thyrotropin and Thyroid Hormone Withdrawal for the Detection of Thyroid Remnant or Cancer1
|The Journal of Clinical Endocrinology & Metabolism|1999|564
Impact of Proto-Oncogene Mutation Detection in Cytological Specimens from Thyroid Nodules Improves the Diagnostic Accuracy of Cytology
|The Journal of Clinical Endocrinology & Metabolism|2010|316
Targeting PI3K/AKT/mTOR network for treatment of leukemia
|Cellular and Molecular Life Sciences|2015|247
miRNA Targets: From Prediction Tools to Experimental Validation
|Methods and Protocols|2020|240